Skip to content

The effect of EPO on collapsed lung injury response to one lung ventilation

The effect of EPO on collapsed lung injury response to one lung ventilation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010601
Enrollment
Unknown
Registered
2017-02-09
Start date
2017-02-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung injury induced by one lung ventilation

Interventions

control group:no
EPO group:EPO

Sponsors

Department of Anaesthesia, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 60 patients aged 20 to 60 years, ASA I-II which undergoing the lobectomy for lung cancer

Exclusion criteria

Exclusion criteria: smoking cessation 35 kg/m2, abnormal lung function (vital capacity or forced expiratory volume in 1 s 10.0×10^9/L), cardiac arrhythmia classified as Lown IIb, or a history of or current non-lung cancer, chronic lung disease (chronic pneumonia, bronchitis, pneumoconiosis, silicosis, or asthma), pleural effusion, or pulmonary hypertension (>30 mmHg).

Design outcomes

Primary

MeasureTime frame
TNF-a in BALF;

Secondary

MeasureTime frame
peak, plat;arterial blood analysis;lung compliance;IL-1 in BALF;IL-6 in BALF;IL-6 in BALF;IL-10 in BALF;

Countries

China

Contacts

Public ContactWei Gao

Department of Anaesthesia, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China

gaowei20055@126.com+86 13836172191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026